Omeprazole Inteli (Omeprazole)

Omeprazole is a proton pump inhibitor used to manage conditions associated with excess gastric acid.

• Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation.
• Erosive oesophagitis: facilitates mucosal repair and decreases further acid damage.
• Peptic ulcer disease: promotes ulcer healing by maintaining a less acidic gastric environment.
• Helicobacter pylori eradication regimen: provides acid suppression that enhances the efficacy of antibiotic therapy.

• Omeprazole irreversibly binds to the H+/K+ ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid secretion, it markedly reduces both basal and stimulated gastric acid output, leading to an increased gastric pH that allows damaged mucosa to heal.

Omeprazole may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Headache: mild headache occurring during therapy.
• Diarrhea: loose stools or increased bowel movements.
• Nausea: feeling of sickness or urge to vomit.
• Abdominal pain: discomfort or cramping in the stomach area.

Serious or Rare Side Effects

• Clostridioides difficile infection: severe colitis presenting with watery diarrhea.
• Acute interstitial nephritis: kidney inflammation causing reduced urine output.
• Stevens‑Johnson syndrome: rare skin reaction with blistering and mucosal involvement.

When prescribing Omeprazole, clinicians should consider several safety and handling precautions.

• Assess renal and hepatic function: adjust use in patients with severe impairment.
• Review concomitant medications: avoid use with drugs that require gastric acidity for absorption.
• Monitor long‑term therapy: prolonged use may increase risk of bone fractures and vitamin B12 deficiency.
• Use the lowest effective dose: limit duration to the shortest period necessary for symptom control.
• Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original packaging.

Omeprazole can affect the pharmacokinetics of several medicines; interactions are categorized by clinical significance.

Major Interactions (Avoid)

• Antifungal agents (e.g., ketoconazole, itraconazole): reduced absorption and efficacy.
• HIV protease inhibitors (e.g., atazanavir): decreased plasma concentrations leading to therapeutic failure.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in anticoagulant effect, monitor INR.
• Digoxin: possible increase in serum levels, observe for toxicity.
• Clopidogrel: reduced activation may diminish antiplatelet activity.